![](../images/joint1.gif)
|
![](../images/castle.jpg) |
![](../images/joint2.gif)
|
![](../images/scotadd.gif)
|
![](../images/purpleline.gif)
|
Clinical
Categorical Courses
Monday, 23 April - Friday, 27 April
Last updated 20 January 2009
|
Cardiac
MRI: Sessions I and II
Monday, 23 April, 11:00 - 13:00, and Wednesday, 25 April, 10:30 - 12:30
Zahi A. Fayad and Cynthia B. Paschal, Organizers |
Educational Objectives:
Upon completion of this session, participants should be able to:
- Explain and apply MR protocols for
determination of cardiac morphology, dynamic function, flow and physiologic status;
- Describe methodology and interpret results
for cardiac MR assessment of acquired and congenital cardiac disease;
- Compare approaches for optimal presentation
and analysis of cardiac MR results.
|
|
Monday,
23 April, 11:00 - 13:00: Session I |
11:00 |
Introduction |
Dudley J. Pennell |
11:25 |
Congenital Heart Disease |
Albert de Roos |
11:50 |
MR Coronary Angiography |
John N. Oshinski |
12:15 |
Atherosclerotic Plaque
Characterization |
Zahi A. Fayad |
12:50 |
Discussion |
|
13:00 |
Adjournment |
|
Wednesday,
25 April, 10:30 - 12:30: Session II |
10:30 |
Assessment of Myocardial
Function |
Jorg Barkhausen |
10:55 |
Assessing Myocardial
Perfusion and Stress Function |
Steven Wolff |
11:20 |
Determining Myocardial
Viability |
Joao A.C. Lima |
11:45 |
Quantitative Image Analysis |
Elliott R. McVeigh |
12:10 |
Discussion |
|
12:30 |
Adjournment |
|
|
Oncologic MR Imaging
Tuesday, 24 April, 10:30 - 12:30
Jelle O. Barentsz and Jeffrey L. Evelhoch, Organizers |
Educational
Objectives: Upon completion of this session, participants should be able
to:
- Apply state-of-the-art methodology for the
detection and staging of cancer;
- Describe benefits of using USIOP for
detection of nodal metastases;
- Explain how MR can be used to improve
response assessment;
- Appraise the potential for spectroscopic
imaging to increase the utility of MR in oncology.
|
|
10:30 |
Cancer Detection
and Staging |
Mitchell D.
Schnall |
10:55 |
Detection of
Nodal Metastases |
Jelle O. Barentsz |
11:20 |
Response
Assessment |
Anwar R. Padhani |
11:45 |
Role of
Spectroscopic Imaging |
Hedvig Hricak |
12:10 |
Discussion |
|
12:30 |
Adjournment |
|
|
Marrow Imaging
Wednesday, 25 April, 10:30 - 12:30
Mark Schweitzer and Bruno van de Berg, Organizers |
Educational
Objectives: Upon completion of this session, participants should be able
to:
- Recognize the patterns of marrow edema and
how to discriminate between the different causes of this condition;
- Identify the characteristics of
osteomyelitis in the patient who has neuropathic arthropathy;
- List the different types of traumatic
disorders of marrow;
- Recognize the different patterns of marrow
findings in multiple myeloma on MR.
|
|
10:30 |
MR of
Osteomyelitis and Neuroarthropathy |
William B.
Morrison |
10:55 |
MR of Traumatic
Marrow Disorders |
Mark Schweitzer |
11:20 |
MR of Multiple
Myeloma |
Bruno van de Berg |
11:45 |
MR of Primary
Bone Tumors |
Mark Davies |
12:10 |
Discussion |
|
12:30 |
Adjournment |
|
|
Brain Spectroscopy
Thursday, 26 April, 10:30 - 12:30
John R. Griffiths and Sarah J. Nelson, Organizers |
Educational
Objectives: Upon completion of this session, participants should be able
to:
- Identify situations where MRS may be
valuable in the assessment of neurological diseases;
- Select the most appropriate techniques for
such applications;
- Identify metabolites in spectra from normal
and diseased brain tissue;
- Recognize common spectral artifacts and
distinguish them from regions of pathology.
|
|
10:30 |
MRS in Routine
Radiology of Brain Masses |
Antoni Capdevila |
11:00 |
MRSI for Planning
Focal Radiation Therapy |
Sarah J. Nelson |
11:30 |
Monitoring
Pediatric Brain Disorders with MRS |
Arend Heerschap |
12:00 |
MRS of Multiple
Sclerosis |
David H. Miller |
12:30 |
Adjournment |
|
|
|
Breast MR Imaging
Friday, 27 April, 10:30 - 12:30
Susan M. Ascher and Christiane K. Kuhl, Organizers |
Educational
Objectives: Upon completion of this session, participants should be able
to:
- Define important technical implications for
performing breast MRI;
- Identify appropriate indications for breast
MRI, and how they compare to other modalities;
- Explain imaging findings based on the
International Working Group on Breast MRI's lexicon;
- List specific diagnostic criteria used in
breast MRI interpretation;
- Recognize breast MRI features of benign and
malignant breast diseases (to include invasive breast cancer and DCIS).
|
|
10:30 |
Introduction |
Debra M. Ikeda |
10:50 |
Technical Aspects |
Nola Hylton |
11:10 |
Image
Interpretation Guidelines |
Christiane K.
Kuhl |
11:30 |
Diagnostic
Accuracy Compared to Conventional Imaging |
Uwe Fischer |
11:50 |
Established and
Evolving Applications |
Mitchell D.
Schnall |
12:10 |
MR-Guided
Interventional Therapy |
Steven E. Harms |
12:30 |
Adjournment |
|
|